|
[1]
|
Banales, J.M., Marin, J.J.G., Lamarca, A., Rodrigues, P.M., Khan, S.A., Roberts, L.R., et al. (2020) Cholangiocarcino-ma 2020: The Next Horizon in Mechanisms and Management. Nature Reviews Gastroenterology & Hepatology, 17, 557-588. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Ruys, A.T., Van Haelst, S., Busch, O.R., Rauws, E.A., Gouma, D.J. and van Gulik, T.M. (2012) Long-Term Survival in Hilar Cholangiocarcinoma also Possible in Unresec-table Patients. World Journal of Surgery, 36, 2179-2186. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Groot Koerkamp, B., Wiggers, J.K., Gonen, M., Doussot, A., Al-len, P.J., Besselink, M.G.H., et al. (2015) Survival after Resection of Perihilar Cholangiocarcinoma Development and External Validation of a Prognostic Nomogram. Annals of Oncology, 26, 1930-1935. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Soares, K.C. and Jarnagin, W.R. (2021) The Landmark Series: Hilar Cholangiocarcinoma. Annals of Surgical Oncology, 28, 4158-4170. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Banales, J.M., Cardinale, V., Carpino, G., Marzioni, M., Andersen, J.B., Invernizzi, P., et al. (2016) Expert Consensus Document: Cholangiocarcinoma: Current Knowledge and Future Perspectives Consensus Statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nature Reviews Gastroenterology & Hepatology, 13, 261-280. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Tran, T.B., Ethun, C.G., Pawlik, T.M., Schmidt, C., Beal, E.W., Fields, R.C., et al. (2019) Actual 5-Year Survivors after Sur-gical Resection of Hilar Cholangiocarcinoma. Annals of Surgical Oncology, 26, 611-618. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Neuhaus, H. (2020) Preoperative Biliary Drainage in Hilar Chol-angiocarcinoma: When and How? Endoscopy International Open, 8, E211-E213. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Ramanathan, R., Borrebach, J., Tohme, S. and Tsung, A. (2018) Pre-operative Biliary Drainage Is Associated with Increased Complications after Liver Resection for Proximal Cholangiocar-cinoma. Journal of Gastrointestinal Surgery, 22, 1950-1957. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Iacono, C., Ruzzenente, A., Campagnaro, T., Bortolasi, L., Val-degamberi, A. and Guglielmi, A. (2013) Role of Preoperative Biliary Drainage in Jaundiced Patients Who Are Candidates for Pancreatoduodenectomy or Hepatic Resection: Highlights and Drawbacks. Annals of Surgery, 257, 191-204. [Google Scholar] [CrossRef]
|
|
[10]
|
Wronka, K.M., Grąt, M., Stypułkowski, J., Bik, E., Patkow-ski, W., Krawczyk, M., et al. (2019) Relevance of Preoperative Hyperbilirubinemia in Patients Undergoing Hepatobiliary Resection for Hilar Cholangiocarcinoma. Journal of Clinical Medicine, 8, Article No. 458. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wiggers, J.K., Koerkamp, B.G., Coelen, R.J., Rauws, E.A., Schattner, M.A., Nio, C.Y., et al. (2015) Preoperative Biliary Drainage in Perihilar Cholangiocarcinoma: Identifying Patients Who Require Percutaneous Drainage after Failed Endoscopic Drainage. Endoscopy, 47, 1124-1131. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Mansour, J.C., Aloia, T.A., Crane, C.H., Heimbach, J.K., Nagino, M. and Vauthey, J.N. (2015) Hilar Cholangiocarcinoma: Expert Consensus Statement. HPB (Oxford), 17, 691-699. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Capobianco, I., Rolinger, J. and Nadalin, S. (2018) Resection for Klatskin Tumors: Technical Complexities and Results. Translational Gastroenterology and Hepatology, 3, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Kawakami, H., Kuwatani, M., Onodera, M., Haba, S., Eto, K., Ehira, N., et al. (2011) Endoscopic Nasobiliary Drainage Is the Most Suitable Preoperative Biliary Drainage Method in the Management of Patients with Hilar Cholangiocarcinoma. Journal of Gastroenterology, 46, 242-248. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Ba, Y., Yue, P., Leung, J.W., Wang, H., Lin, Y., Bai, B., et al. (2020) Percutaneous Transhepatic Biliary Drainage May Be the Preferred Preoperative Drainage Method in Hilar Chol-angiocarcinoma. Endoscopy International Open, 8, E203-E210. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Groeschl, R.T. and Nagorney, D.M. (2016) Portal Vein Reconstruction during Surgery for Cholangiocarcinoma. Current Opinion in Gastroenterology, 32, 216-224. [Google Scholar] [CrossRef]
|
|
[17]
|
中国抗癌协会. 肝门部胆管癌规范化诊治专家共识(2015) [J] .中华肝胆外科杂志, 2015, 21(8): 505-511.
|
|
[18]
|
Nagino, M., Ebata, T., Yokoyama, Y., Igami, T., Sugawara, G., Takahashi, Y., et al. (2013) Evolution of Surgical Treatment for Perihilar Chol-angiocarcinoma: A Single-Center 34-Year Review of 574 Consecutive Resections. Annals of Surgery, 258, 129-140. [Google Scholar] [CrossRef]
|
|
[19]
|
Buettner, S., Margonis, G.A., Kim, Y., Gani, F., Ethun, C.G., Poultsides, G., et al. (2016) Conditional Probability of Long-Erm Survival after Resection of Hilar Cholangiocar-cinoma. HPB (Oxford), 18, 510-517. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Bhardwaj, N., Garcea, G., Dennison, A.R. and Maddern, G.J. (2015) The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade? World Journal of Surgery, 39, 2748-2756. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Birgin, E., Rasbach, E., Reissfelder, C. and Rahbari, N.N. (2020) A Systematic Review and Meta-Analysis of Caudate Lobectomy for Treatment of Hilar Cholangiocarcinoma. European Journal of Surgical Oncology, 46, 747-753. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
王曙光, 李智华, 何宇. 李大江, 杨占宇, 别平. 哑铃式肝门部胆管癌根治术[J]. 中华消化外科杂志, 2013, 12(3): 181-185.
|
|
[23]
|
Mantel, H.T., Wiggers, J.K., Verheij, J., Doff, J.J., Sieders, E., van Gulik, T.M., et al. (2015) Lymph Node Micrometastases Are Associated with Worse Survival in Patients with Otherwise Node-Negative Hilar Cholangiocarcinoma. Annals of Surgical Oncology, 22, 1107-1115. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Conci, S., Ruzzenente, A., Sandri, M., Bertuzzo, F., Campagnaro, T., Bagante, F., et al. (2017) What Is the Most Accurate Lymph Node Staging Method for Perihilar Cholangiocarcinoma? Comparison of UICC/AJCC PN Stage, Number of Metastatic Lymph Nodes, Lymph Node Ratio, and Log Odds of Metastatic Lymph Nodes. European Journal of Surgical Oncology, 43, 743-750. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Giuliante, F., Ardito, F., Guglielmi, A., Aldrighetti, L., Ferrero, A., Calise, F., et al. (2016) Association of Lymph Node Status with Survival in Patients after Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis. JAMA Surgery, 151, 916-922. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Aoba, T., Ebata, T., Yokoyama, Y., Igami, T., Sugawara, G., Takahashi, Y., et al. (2013) Assessment of Nodal Status for Perihilar Cholangiocarcinoma: Location, Number, or Ratio of Involved Nodes. Annals of Surgery, 257, 718-725. [Google Scholar] [CrossRef]
|
|
[27]
|
Mao, K., Liu, J., Sun, J., Zhang, J., Chen, J., Pawlik, T.M., et al. (2016) Patterns and Prognostic Value of Lymph Node Dissection for Resected Perihilar Cholangiocarcinoma. Journal of Gastroenterology and Hepatology, 31, 417-426. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Ma, W.J., Wu, Z.R., Hu, H.J., Wang, J.K., Yin, C.H., Shi, Y.J., et al. (2020) Extended Lymphadenectomy versus Regional Lymphadenectomy in Resectable Hilar Cholangiocarcinoma. Journal of Gastrointestinal Surgery, 24, 1619-1629. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
孟令军, 张晓荣, 杨保金. 扩大的腹主动脉旁淋巴结清扫可改善Bismuth I/II型肝门部胆管癌患者术后生存[J]. 实用肝脏病杂志, 2018, 21(5): 761-764.
|
|
[30]
|
Hakeem, A.R., Marangoni, G., Chapman, S.J., Young, R.S., Nair, A., Hidalgo, E.L., et al. (2014) Does the Extent of Lymphadenectomy, Number of Lymph Nodes, Positive Lymph Node Ratio and Neutrophil-Lymphocyte Ratio Impact Surgical Outcome of Perihilar Cholangiocarcinoma? European Journal of Gastroenterology & Hepatology, 26, 1047-1054. [Google Scholar] [CrossRef]
|
|
[31]
|
Ramos, E. (2013) Principles of Surgical Resection in Hilar Cholangiocarcinoma. World Journal of Gastrointestinal Oncology, 5, 139-146. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Matsuyama, R., Mori, R., Ota, Y., Homma, Y., Kumamoto, T., Takeda, K., et al. (2016) Significance of Vascular Resection and Reconstruction in Surgery for Hilar Cholangiocarcinoma: with Special Reference to Hepatic Arterial Resection and Reconstruction. Annals of Surgical Oncology, 23, 475-484. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Olthof, P.B., Wiggers, J.K., Groot, K.B., Coelen, R.J., Allen, P.J., Besselink, M.G., et al. (2017) Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization. Journal of the American College of Surgeons, 225, 387-394. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Hoffmann, K., Luible, S., Goeppert, B., Weiss, K.H., Hinz, U., Büchler, M.W., et al. (2015) Impact of Portal Vein Resection on Oncologic Long-Term Outcome in Patients with Hi-lar Cholangiocarcinoma. Surgery, 158, 1252-1260. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Schimizzi, G.V., Jin, L.X., Davidson, J.T., Krasnick, B.A., Ethun, C.G., Pawlik, T.M., et al. (2018) Outcomes after Vascular Resection during Curative-Intent Resection for Hilar Cholan-giocarcinoma: A Multi-Institution Study from the US Extrahepatic Biliary Malignancy Consortium. HPB (Oxford), 20, 332-339. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Chin, K.M., Chua, D.W.Q., Lee, S.Y., Chan, C.Y. and Goh, B.K.P. (2021) Outcome of Minimally Invasive Liver Resection for Extrapancreatic Biliary Malignancies: A Single-Institutional Experience. Journal of Minimal Access Surgery, 17, 69-75. [Google Scholar] [CrossRef]
|
|
[37]
|
Zhang, Y., Dou, C., Wu, W., Liu, J., Jin, L., Hu, Z., et al. (2020) Total Laparoscopic versus Open Radical Resection for Hilar Cholangiocarcinoma. Surgical Endoscopy, 34, 4382-4387. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Ratti, F., Fiorentini, G., Cipriani, F., Catena, M., Paganelli, M. and Aldrighetti, L. (2020) Perihilar Cholangiocarcinoma: Are We Ready to Step Towards Minimally Invasiveness? Up-dates in Surgery, 72, 423-433. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Feng, F., Cao, X., Liu, X., Qin, J., Zhang, S., Li, Q., et al. (2019) Laparoscopic Resection for Bismuth Type III and IV Hilar Cholangiocarcinoma: How to Improve the Radicality without Direct Palpation. Journal of Surgical Oncology, 120, 1379-1385. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
丁剑毅, 张宇华, 黄东胜. 腹腔镜肝门部胆管癌切除术治疗进展[J]. 中华肝胆外科杂志, 2020, 26(11): 870-873.
|
|
[41]
|
腹腔镜肝门部胆管癌根治切除术操作规范专家组, 中华外科杂志编辑部. 腹腔镜肝门部胆管癌根治性切除操作流程专家建议[J]. 中华外科杂志, 2019, 57(8): 561-567.
|
|
[42]
|
Meyer, C.G., Penn, I. and James, L. (2000) Liver Transplan-tation for Cholangiocarcinoma: Results in 207 Patients. Transplantation, 69, 1633-1637. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Rea, D.J., Heimbach, J.K., Rosen, C.B., Haddock, M.G., Alberts, S.R., Kremers, W.K., et al. (2005) Liver Transplantation with Neoadjuvant Chemoradiation Is More Effective Than Resection for Hilar Cholangiocarcinoma. Annals of Surgery, 242, 451-461. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Azad, A.I., Rosen, C.B., Taner, T., Heimbach, J.K. and Gores, G.J. (2020) Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation. Cancers, 12, Article No. 3157. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Ethun, C.G., Lopez-Aguiar, A.G., Anderson, D.J., Adams, A.B., Fields, R.C., Doyle, M.B., et al. (2018) Transplantation versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease. Annals of Surgery, 267, 797-805. [Google Scholar] [CrossRef]
|
|
[46]
|
Zaborowski, A., Heneghan, H.M., Fiore, B., Stafford, A., Gallagher, T., Geoghegan, J., et al. (2020) Neoadjuvant Chemoradiotherapy and Liver Transplantation for Unresectable Hilar Cholangiocarcinoma: The Irish Experience of the Mayo Protocol. Transplantation, 104, 2097-2104. [Google Scholar] [CrossRef]
|
|
[47]
|
Plentz, R.R. and Malek, N.P. (2016) Systemic Therapy of Cholangiocarcinoma. Visceral Medicine, 32, 427-430. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Gani, F., Nagarajan, N., Kim, Y., Zhu, Q., Luan, L., Bhaijjee, F., et al. (2016) Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients with Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology, 23, 2610-2617. [Google Scholar] [CrossRef] [PubMed]
|